Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3846311 | Advances in Chronic Kidney Disease | 2015 | 8 Pages |
Abstract
Liver transplantation is the standard of care for patients with decompensated cirrhosis. Liver transplantation recipients have excellent short-term and long-term outcomes including patient and graft survival. Since the adoption of model for end-stage liver disease (MELD)-based allocation policy, the incidence of post-transplant end stage renal disease has risen significantly. Occurrence of Stage 4 chronic kidney disease and end stage renal disease substantially increases the risk of post-transplant deaths. Because majority of late post-transplant mortality is due to nonhepatic post-transplant comorbidities, personalized care directed toward risk factor modification may further improve post-transplant survival.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Pratima Sharma, Khurram Bari,